PRILOTEKAL

This brand name is authorized in Netherlands, Poland, United Kingdom

Active ingredients

The drug PRILOTEKAL contains one active pharmaceutical ingredient (API):

1 Prilocaine
UNII MJW015BAPH - PRILOCAINE HYDROCHLORIDE

Prilocaine is a toluidine derivative and intermediate-acting amino amide with local anesthetic property. Prilocaine binds to the intracellular surface of sodium channels which blocks the subsequent influx of sodium into the cell. Action potential propagation and never function is, therefore, prevented. This block is reversible and when the drug diffuses away from the cell, sodium channel function is restored and nerve propagation returns.

Read about Prilocaine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PRILOTEKAL Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N01BB04 Prilocaine N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 171903
Country: NL Z-Index G-Standaard, PRK Identifier(s): 106852
Country: PL Rejestru Produktรณw Leczniczych Identifier(s): 100317432

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.